Can stability bracketing and/or matrixing be used to determine the packaging configurations to be placed on stability for an original ANDA without prior approval from the Office of Generic Drugs (OGD)?

Yes. You should follow the International Conference on Harmonisation (ICH)
guidance for industry on Q1D Bracketing and Matrixing Designs for Stability
Testing of New Drug Substances and Products and its example tables.